Kenvue Canada
Canada Updated 9 July 2026
Kenvue Canada is a finished-dose manufacturer based in Canada. It appears in 82 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 1 December 2017 as NAI.
1
registered plants
1 with an FDA FEI number
82
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 1 December 2017 NAI US FDA
- 23 July 2010 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Canada, Canada | 1000328785 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| Health Canada | 82 | None |
Comparing suppliers?
Choose your molecules and target markets. Kenvue Canada comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 1 December 2017.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability